An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma.

Cell Rep Methods · 2024 · PMC10985229 · PMID 38430913

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The increase in CXCL9 production between MOIs 0.3 and 30 followed a similar pattern but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.